Series E - NGM Biopharmaceuticals - Mar 25, 2015 Funding Round Profile - Cointime

比特币 ¥471,845.09 +0.80%
以太坊 ¥22,747.10 -4.42%
币安币 ¥4,095.93 -0.34%
Optimism ¥12.14 -2.92%
Arbitrum ¥5.00 -5.76%
Solana ¥1,233.78 -2.91%
Polygon ¥3.55 -4.43%
Cosmos ¥42.13 -2.33%
Avalanche ¥196.48 -4.22%

比特币 ¥471,845.09 +0.80%
以太坊 ¥22,747.10 -4.42%
币安币 ¥4,095.93 -0.34%
Optimism ¥12.14 -2.92%
Arbitrum ¥5.00 -5.76%
Solana ¥1,233.78 -2.91%
Polygon ¥3.55 -4.43%
Cosmos ¥42.13 -2.33%
Avalanche ¥196.48 -4.22%

NGM Biopharmaceuticals

company

Funding Round

Series E

Money Raised

$ 105.99M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Merck	-	Yes	-	Detail